Natco Pharma Ltd. NSE: NATCOPHARM | BSE: 524816

Mid-range Performer

Download real time

881.95 -6.90 (-0.78%)

46.19% Fall from 52W High

167.4K

NSE+BSE Volume

NSE 21 Aug, 2025 10:14 AM (IST)

Drug Launch

Natco Pharma launches its Bosentan tablets in the US, with a market size of $10 mn See details

Natco Pharma Ltd. Earnings/Conference Calls

Natco Pharma Ltd. earnings concalls and investor presentations

Is Natco Pharma Ltd. worth buying?

561 Votes:

Buy 83.07%

Sell 7.49%

Hold 9.45%

RESEARCH REPORTS

Hold SEE REPORTS >

Hold SEE REPORTS >